GRI Bio, Inc. (GRI)
1.93
+0.09
(+4.89%)
USD |
NASDAQ |
Sep 18, 16:00
1.90
-0.03
(-1.55%)
After-Hours: 20:00
GRI Bio Market Cap : 4.219M for Sept. 18, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 18, 2026 | 4.219M |
| September 17, 2026 | 4.022M |
| September 16, 2026 | 3.957M |
| September 15, 2026 | 3.979M |
| September 14, 2026 | 4.132M |
| September 11, 2026 | 4.154M |
| September 10, 2026 | 4.241M |
| September 09, 2026 | 3.935M |
| September 08, 2026 | 4.372M |
| September 04, 2026 | 6.296M |
| September 03, 2026 | 5.006M |
| September 02, 2026 | 4.372M |
| September 01, 2026 | 4.176M |
| August 31, 2026 | 4.197M |
| August 28, 2026 | 4.197M |
| August 27, 2026 | 4.525M |
| August 26, 2026 | 4.176M |
| August 25, 2026 | 4.285M |
| August 24, 2026 | 3.913M |
| August 21, 2026 | 3.607M |
| August 20, 2026 | 3.651M |
| August 19, 2026 | 3.782M |
| August 18, 2026 | 3.738M |
| August 17, 2026 | 3.782M |
| August 14, 2026 | 3.651M |
| Date | Value |
|---|---|
| August 13, 2026 | 3.869M |
| August 12, 2026 | 4.263M |
| August 11, 2026 | 4.809M |
| August 10, 2026 | 2.694M |
| August 07, 2026 | 2.330M |
| August 06, 2026 | 2.457M |
| August 05, 2026 | 2.425M |
| August 04, 2026 | 2.52M |
| August 03, 2026 | 2.282M |
| July 31, 2026 | 2.187M |
| July 30, 2026 | 2.235M |
| July 29, 2026 | 2.330M |
| July 28, 2026 | 2.266M |
| July 27, 2026 | 2.219M |
| July 24, 2026 | 2.298M |
| July 23, 2026 | 2.377M |
| July 22, 2026 | 2.346M |
| July 21, 2026 | 2.393M |
| July 20, 2026 | 2.330M |
| July 17, 2026 | 2.377M |
| July 16, 2026 | 2.441M |
| July 15, 2026 | 2.568M |
| July 14, 2026 | 2.488M |
| July 13, 2026 | 2.568M |
| July 10, 2026 | 2.758M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 4.697B |
| Alnylam Pharmaceuticals, Inc. | 32.04B |
| Anika Therapeutics, Inc. | 278.50M |
| Savara, Inc. | 1.103B |
| Vericel Corp. | 2.048B |
Market Cap Related Metrics
| Price to Book Value | 0.4104 |
| Price | 1.93 |
| Earnings Yield | -2.27K% |